TXMDTherapeuticsMD, Inc.Aug 15, 2022Q2 2022
Read transcript →TherapeuticsMD, Inc. (TXMD)
NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic
$2.13
+2.90%
Mkt Cap $26.62M
TXMDTherapeuticsMD, Inc.Aug 15, 2022TXMDTherapeuticsMD, Inc.May 16, 2022Q1 2022
Read transcript →TXMDTherapeuticsMD, Inc.Mar 10, 2022Q4 2021
Read transcript →TXMDTherapeuticsMD, Inc.Nov 11, 2021Q3 2021
Read transcript →TXMDTherapeuticsMD, Inc.Aug 4, 2021Q2 2021
Read transcript →TXMDTherapeuticsMD, Inc.May 6, 2021Q1 2021
Read transcript →TXMDTherapeuticsMD, Inc.Mar 2, 2021Q4 2020
Read transcript →TXMDTherapeuticsMD, Inc.Nov 9, 2020Q3 2020
Read transcript →TXMDTherapeuticsMD, Inc.Aug 7, 2020Q2 2020
Read transcript →TXMDTherapeuticsMD, Inc.May 6, 2020Q1 2020
Read transcript →TXMDTherapeuticsMD, Inc.Feb 20, 2020Q4 2019
Read transcript →TXMDTherapeuticsMD, Inc.Nov 6, 2019Q3 2019
Read transcript →TXMDTherapeuticsMD, Inc.Aug 6, 2019Q2 2019
Read transcript →TXMDTherapeuticsMD, Inc.May 6, 2019Q1 2019
Read transcript →TXMDTherapeuticsMD, Inc.Feb 22, 2019Q4 2018
Read transcript →TXMDTherapeuticsMD, Inc.Nov 8, 2018Q3 2018
Read transcript →TXMDTherapeuticsMD, Inc.Jul 30, 2018Q2 2018
Read transcript →TXMDTherapeuticsMD, Inc.May 4, 2018Q1 2018
Read transcript →TXMDTherapeuticsMD, Inc.Feb 20, 2018Q4 2017
Read transcript →TXMDTherapeuticsMD, Inc.Nov 6, 2017Q3 2017
Read transcript →TXMDTherapeuticsMD, Inc.Aug 3, 2017Q2 2017
Read transcript →TXMDTherapeuticsMD, Inc.Feb 23, 2017Q4 2016
Read transcript →TXMDTherapeuticsMD, Inc.Nov 3, 2016Q3 2016
Read transcript →TXMDTherapeuticsMD, Inc.Aug 4, 2016Q2 2016
Read transcript →TXMDTherapeuticsMD, Inc.May 3, 2016Q1 2016
Read transcript →TXMDTherapeuticsMD, Inc.Feb 25, 2016Q4 2015
Read transcript →TXMDTherapeuticsMD, Inc.Nov 4, 2015Q3 2015
Read transcript →TXMDTherapeuticsMD, Inc.Aug 6, 2015Q2 2015
Read transcript →TXMDTherapeuticsMD, Inc.May 5, 2015Q1 2015
Read transcript →TXMDTherapeuticsMD, Inc.Mar 10, 2015Q4 2014
Read transcript →TXMDTherapeuticsMD, Inc.Nov 9, 2014Q3 2014
Read transcript →TXMDTherapeuticsMD, Inc.Aug 8, 2014Q2 2014
Read transcript →